billiontoone.comHealthcareFounded: 2016Funding to Date: $213.55MM
BillionToOne is the developer of a patent-pending QCT molecular counter platform designed to accurately count DNA molecules to the single-count level.
For more details on financing and valuation for BillionToOne, register or login.
View Enterprise Value for BillionToOne.
To read this article and more news on BillionToOne, register or login.